Steve Cohen: portfolio of Point72 Asset Management

Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2024. Go to the latest filing (Q3 2026)

35.7B USDQ4 2024
Total value of stock positions
35.7B USD
Positions
1,190
Share of the ten largest
13.3%

The ten largest positions Q4 2024

  1. Amazon 2.6%new
  2. Microsoft 2.0%▲ +356.9%
  3. Nvidia 1.6%▲ +13.5%
  4. Taiwan Semiconductor Manufacturing (ADR) 1.4%▲ +106.7%
  5. Coca-Cola Company (The) 1.0%▲ +450.3%
  6. AT&T 1.0%new
  7. Intuit 1.0%▲ +2,450.4%
  8. Walt Disney Company (The) 1.0%new
  9. Arista Networks 0.9%▼ −14.0%
  10. Adobe Inc. 0.9%▲ +180.7%
Total value of stock positions per quarter, Q2 2014 to Q3 2026 (peak 62.9B USD).
Choose a quarter (50 filings)

All positions Q4 2024

Positions Q4 2024 per 13F filing, 50 of 314
Symbol Weight Shares Reported value Change Held since
CME CME Group < 0.1% 15,000 3.5M USD −84.7% reduced Q2 2014 or earlier 43 quarters
DD DuPont < 0.1% 136,605 10.4M USD −52.0% reduced Q2 2019 23 quarters
Alphatec HLDGS Inc < 0.1% 598,003 5.5M USD −30.5% reduced Q4 2020 17 quarters
ANET Arista Networks 0.9% 3,021,154 333.9M USD −14.0% reducedafter 4:1 stock split Q1 2021 16 quarters
VMC Vulcan Materials Company < 0.1% 55,989 14.4M USD −47.1% reduced Q1 2021 16 quarters
Olin Corp < 0.1% 29,444 995.2K USD −92.3% reduced Q1 2021 16 quarters
Triumph Group Inc New < 0.1% 866,936 16.2M USD −22.0% reduced Q2 2021 15 quarters
BSX Boston Scientific 0.6% 2,245,799 200.6M USD −33.6% reduced Q3 2021 14 quarters
Bath & Body Works Inc 0.4% 3,873,396 150.2M USD −22.8% reduced Q3 2021 14 quarters
Ambarella Inc 0.2% 802,280 58.4M USD −6.9% reduced Q3 2021 14 quarters
CRDO Credo Technology Group 0.6% 3,084,621 207.3M USD −21.2% reduced Q1 2022 12 quarters
Bellring Brands Inc 0.3% 1,537,883 115.9M USD −40.6% reduced Q1 2022 12 quarters
Webster Finl Corp 0.2% 1,222,758 67.5M USD −11.8% reduced Q1 2022 12 quarters
COO Cooper Companies (The) < 0.1% 179,139 16.5M USD −5.0% reduced Q1 2022 12 quarters
Health Catalyst Inc < 0.1% 215,160 1.5M USD −58.4% reduced Q1 2022 12 quarters
Axsome Therapeutics Inc < 0.1% 185,138 15.7M USD −65.9% reduced Q2 2022 11 quarters
Joyy Inc < 0.1% 312,927 13.1M USD −12.6% reduced Q2 2022 11 quarters
Mastec Inc 0.3% 734,211 100.0M USD −3.9% reduced Q3 2022 10 quarters
UAL United Airlines Holdings 0.1% 551,933 53.6M USD −64.9% reduced Q3 2022 10 quarters
Biohaven Ltd < 0.1% 922,965 34.5M USD −38.5% reduced Q3 2022 10 quarters
Rogers Communications Inc < 0.1% 937,328 28.8M USD −72.5% reduced Q3 2022 10 quarters
Discover Finl Svcs < 0.1% 155,132 26.9M USD −48.3% reduced Q3 2022 10 quarters
Rxsight Inc < 0.1% 391,732 13.5M USD −12.4% reduced Q3 2022 10 quarters
Gibraltar Inds Inc < 0.1% 190,588 11.2M USD −9.3% reduced Q3 2022 10 quarters
Sterling Infrastructure Inc < 0.1% 29,695 5.0M USD −76.2% reduced Q3 2022 10 quarters
Helix Energy Solutions Grp I < 0.1% 277,835 2.6M USD −82.1% reduced Q3 2022 10 quarters
Wayfair Inc < 0.1% 13,200 585.0K USD −83.4% reduced Q3 2022 10 quarters
Keros Therapeutics Inc < 0.1% 1,592 25.2K USD −99.8% reduced Q3 2022 10 quarters
ISRG Intuitive Surgical 0.5% 338,696 176.8M USD −22.6% reduced Q4 2022 9 quarters
Qorvo Inc 0.2% 865,162 60.5M USD −9.5% reduced Q4 2022 9 quarters
Syndax Pharmaceuticals Inc < 0.1% 1,915,736 25.3M USD −31.0% reduced Q4 2022 9 quarters
Crown HLDGS Inc < 0.1% 182,822 15.1M USD −51.5% reduced Q4 2022 9 quarters
HAS Hasbro < 0.1% 193,171 10.8M USD −75.1% reduced Q4 2022 9 quarters
Liberty Broadband Corp < 0.1% 58,020 4.3M USD −80.3% reduced Q4 2022 9 quarters
Caribou Biosciences Inc < 0.1% 1,024,989 1.6M USD −51.9% reduced Q4 2022 9 quarters
Nlight Inc < 0.1% 24,400 256.0K USD −57.8% reduced Q4 2022 9 quarters
COF Capital One 0.2% 381,730 68.1M USD −37.6% reduced Q1 2023 8 quarters
Skechers U S A Inc 0.2% 975,797 65.6M USD −58.6% reduced Q1 2023 8 quarters
RAPID7 Inc 0.2% 1,485,477 59.8M USD −54.2% reduced Q1 2023 8 quarters
Livanova PLC 0.1% 1,036,248 48.0M USD −50.5% reduced Q1 2023 8 quarters
Cogent Biosciences Inc 0.1% 5,347,302 41.7M USD −48.9% reduced Q1 2023 8 quarters
JCI Johnson Controls 0.1% 513,449 40.5M USD −58.6% reduced Q1 2023 8 quarters
Reinsurance Grp Of America I < 0.1% 125,812 26.9M USD −32.8% reduced Q1 2023 8 quarters
WAB Wabtec < 0.1% 131,700 25.0M USD −24.3% reduced Q1 2023 8 quarters
Griffon Corp < 0.1% 272,065 19.4M USD −42.5% reduced Q1 2023 8 quarters
Patterson-Uti Energy Inc < 0.1% 1,844,659 15.2M USD −45.9% reduced Q1 2023 8 quarters
Topbuild Corp < 0.1% 41,546 12.9M USD −54.4% reduced Q1 2023 8 quarters
Heico Corp New < 0.1% 69,203 12.9M USD −3.8% reduced Q1 2023 8 quarters
Gds HLDGS Ltd < 0.1% 100,554 2.4M USD −34.3% reduced Q1 2023 8 quarters
Stride Inc < 0.1% 9,251 961.4K USD −95.6% reduced Q1 2023 8 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 314 positions.

Plus 804 option positions, value of the underlying shares as reported 8.9B USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • SPDR S&P 500 ETF TR Call 1.7B USD
  • SPDR S&P 500 ETF TR Put 1.7B USD
  • Ishares TR Put 239.7M USD
  • Invesco QQQ TR Put 162.3M USD
  • Apple Inc. Call 118.6M USD
  • Hershey Company (The) Call 70.8M USD
  • Novo Nordisk (ADR) Put 68.8M USD
  • Select Sector SPDR TR Put 65.7M USD
  • Ishares TR Call 61.9M USD
  • Apple Inc. Put 54.9M USD
Plus 44 positions in convertible bonds and bonds worth 765.0M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Axon Enterprise Inc principal 20.0M USD 52.2M USD
  • Microstrategy Inc principal 23.0M USD 47.7M USD
  • Bridgebio Pharma Inc principal 37.5M USD 39.3M USD
  • Lumentum HLDGS Inc principal 33.5M USD 37.0M USD
  • Cytokinetics Inc principal 29.7M USD 35.5M USD
  • Ascendis Pharma A/S principal 31.5M USD 34.7M USD
  • Ncl Corp Ltd principal 32.6M USD 34.2M USD
  • Mirum Pharmaceuticals Inc principal 18.9M USD 28.8M USD
  • Ncl Corp Ltd principal 20.0M USD 28.7M USD
  • Insulet Corp principal 22.5M USD 28.5M USD

Breakdown by sector

  • Technology 18.7%
  • Consumer Discretionary 6.4%
  • Health Care 6.0%
  • Industrials 5.4%
  • Financials 4.1%
  • Utilities 3.5%
  • Communication Services 3.5%
  • Consumer Staples 3.5%
  • Energy 2.6%
  • Materials 1.8%
  • Real Estate 1.2%
  • not in our coverage 43.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close